Organon & Co. (OGN)
8.05
-0.08
(-0.98%)
USD |
NYSE |
Jan 09, 16:00
8.045
0.00 (0.00%)
After-Hours: 20:00
Organon EPS Diluted (Quarterly): 0.6138 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.316 |
| Amgen, Inc. | 5.934 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Rockwell Medical, Inc. | -0.0487 |
| United Therapeutics Corp. | 7.161 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 160.00M |
| Revenue (Quarterly) | 1.602B |
| Total Expenses (Quarterly) | 1.442B |
| Enterprise Value | 10.25B |
| Gross Profit Margin (Quarterly) | 53.50% |
| Profit Margin (Quarterly) | 9.99% |
| Earnings Yield | 23.90% |
| Operating Earnings Yield | 62.63% |
| Normalized Earnings Yield | 26.63 |